Koen B Pouwels1, Thomas House2, Emma Pritchard3, Julie V Robotham4, Paul J Birrell5, Andrew Gelman6, Karina-Doris Vihta3, Nikola Bowers7, Ian Boreham7, Heledd Thomas7, James Lewis7, Iain Bell7, John I Bell8, John N Newton9, Jeremy Farrar10, Ian Diamond7, Pete Benton7, Ann Sarah Walker11. 1. Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, University of Oxford, Oxford, UK. Electronic address: koen.pouwels@ndph.ox.ac.uk. 2. Department of Mathematics, University of Manchester, Manchester, UK; IBM Research, Hartree Centre, Sci-Tech, Daresbury, UK. 3. The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK. 4. National Infection Service, Public Health England, London, UK. 5. National Infection Service, Public Health England, London, UK; Medical Research Council (MRC) Biostatistics Unit, University of Cambridge, Cambridge Institute of Public Health, Cambridge, UK. 6. Department of Statistics, Columbia University, New York, NY, USA. 7. Office for National Statistics, Newport, UK. 8. Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK. 9. Health Improvement Directorate, Public Health England, London, UK. 10. Wellcome Trust, London, UK. 11. The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; MRC Clinical Trials Unit at University College London, London, UK.
Abstract
BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29-0·54) to 0·06% (0·04-0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17-24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17-24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45-68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care.
BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29-0·54) to 0·06% (0·04-0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17-24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17-24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45-68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care.
Authors: Chris Holmes; Sylvia Richardson; George Nicholson; Marta Blangiardo; Mark Briers; Peter J Diggle; Tor Erlend Fjelde; Hong Ge; Robert J B Goudie; Radka Jersakova; Ruairidh E King; Brieuc C L Lehmann; Ann-Marie Mallon; Tullia Padellini; Yee Whye Teh Journal: Stat Sci Date: 2022-05 Impact factor: 4.015
Authors: Lennard Y W Lee; Stefan Rozmanowski; Matthew Pang; Andre Charlett; Charlotte Anderson; Gareth J Hughes; Matthew Barnard; Leon Peto; Richard Vipond; Alex Sienkiewicz; Susan Hopkins; John Bell; Derrick W Crook; Nick Gent; A Sarah Walker; Tim E A Peto; David W Eyre Journal: Clin Infect Dis Date: 2022-02-11 Impact factor: 9.079
Authors: Ellen Brooks-Pollock; Leon Danon; Thibaut Jombart; Lorenzo Pellis Journal: Philos Trans R Soc Lond B Biol Sci Date: 2021-05-31 Impact factor: 6.671
Authors: Martyn Fyles; Elizabeth Fearon; Christopher Overton; Tom Wingfield; Graham F Medley; Ian Hall; Lorenzo Pellis; Thomas House Journal: Philos Trans R Soc Lond B Biol Sci Date: 2021-05-31 Impact factor: 6.237
Authors: Tasnim Hasan; Thach Ngoc Pham; Thu Anh Nguyen; Hien Thi Thu Le; Duyet Van Le; Thuy Thi Dang; Trang Dinh Van; Yen Ngoc Pham; Ha Viet Nguyen; Giang Linh Tran; Van Thi Cam Nguyen; Thanh Trung Nguyen; Viet Quang Truong; Than Huu Dao; Chung Thanh Le; Nam Tan Truong; Hoang Trung Vo; Phuc Thanh Le; Thao Thanh Nguyen; Vinh Van Luu; Vinh Dai Nguyen; Brett G Toelle; Guy B Marks; Greg J Fox Journal: Int J Environ Res Public Health Date: 2021-06-11 Impact factor: 3.390
Authors: Koen B Pouwels; David W Eyre; A Sarah Walker; Jia Wei; Nicole Stoesser; Philippa C Matthews; Daniel Ayoubkhani; Ruth Studley; Iain Bell; John I Bell; John N Newton; Jeremy Farrar; Ian Diamond; Emma Rourke; Alison Howarth; Brian D Marsden; Sarah Hoosdally; E Yvonne Jones; David I Stuart; Derrick W Crook; Tim E A Peto Journal: Nat Microbiol Date: 2021-07-21 Impact factor: 17.745
Authors: Nicole Stoesser; Philippa C Matthews; David W Eyre; A Sarah Walker; Emma Pritchard; Thomas House; Julie V Robotham; Paul J Birrell; Iain Bell; John I Bell; John N Newton; Jeremy Farrar; Ian Diamond; Ruth Studley; Jodie Hay; Karina-Doris Vihta; Timothy Ea Peto; Koen B Pouwels Journal: Elife Date: 2021-07-12 Impact factor: 8.140
Authors: Katherine M Gaskell; Marina Johnson; Victoria Gould; Adam Hunt; Neil Rh Stone; William Waites; Ben Kasstan; Tracey Chantler; Sham Lal; Chrissy H Roberts; David Goldblatt; Rosalind M Eggo; Michael Marks Journal: Lancet Reg Health Eur Date: 2021-07